GLSI financials
Greenwich LifeSciences (GLSI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
GLSI income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$19.45M | -$19.36M | -1.43 |
| 2024 | – | – | -$17.64M | -$17.41M | -1.34 |
| 2023 | – | – | -$9.33M | -$8.89M | -0.69 |
| 2022 | – | – | -$8.04M | -$7.83M | -0.61 |
| 2021 | – | – | -$4.60M | -$4.57M | -0.35 |
| 2020 | – | – | -$1.86M | -$1.86M | -0.20 |